| Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients. [Journal Article]
Prescrire Int 2008 Oct; 17(97):195.
Abstract | Full Citation | Find Related Articles |
| Belhani D, Fanton L, Vaillant F, et al.
Cardiac Lesions Induced by Testosterone: Protective Effects of Dexrazoxane and Trimetazidine. [JOURNAL ARTICLE]
Cardiovasc Toxicol 2009 May 12.
Abstract | Full Citation | Find Related Articles |
| Yan T, Deng S, Metzger A, et al.
Topoisomerase II{alpha}-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin. [JOURNAL ARTICLE]
Mol Cancer Ther 2009 May 5.
Abstract | Full Citation | Find Related Articles |
| Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide. [Journal Article]
Prescrire Int 2009 Feb; 18(99):6-8.
Abstract | Full Citation | Find Related Articles |
| Simůnek T, Stérba M, Popelová O, et al.
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. [Journal Article]
Pharmacol Rep 2009 Jan-Feb; 61(1):154-71.
Abstract | Full Citation | Find Related Articles |
| Kik K, Studzian K, Wąsowska-Łukawska M, et al.
Cytotoxicity and inhibitory properties against topoisomerase II of doxorubicin and its formamidine derivatives. [JOURNAL ARTICLE]
Acta Biochim Pol 2009 Feb 23.
Abstract | Full Citation |
| Attia SM, Al-Anteet AA, Al-Rasheed NM, et al.
Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2009 Jan 30.
Abstract | Full Citation | Find Related Articles |
| Maeda M
Late effects of childhood cancer: life-threatening issues. [Journal Article, Review]
J Nippon Med Sch 2008 Dec; 75(6):320-4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Schulmeister L
Dexrazoxane treatment for intrathoracic anthracycline extravasation. [Comment, Letter]
Onkologie 2008 Nov; 31(11):634.
Full Citation | Publisher Full Text | Find Related Articles |
| Gligorov J, Lotz JP
Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2008 Dec 20.
Abstract | Full Citation | Find Related Articles |
   |
